COMMUNIQUÉS West-GlobeNewswire

Krystal Biotech to Present at BofA Securities 2026 Health Care Conference
07/05/2026
PITTSBURGH, May 07, 2026 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) today announced that the Company will participate in the BofA Securities 2026 Health Care Conference on May 13, 2026, in [...]
Biotech’s Next Wave May Already be in Motion
07/05/2026
Insider Bets on what may become a Brain Cancer Moonshot DENVER, May 07, 2026 (GLOBE NEWSWIRE) -- ( www.247marketnews.com and NeOnc Technology) - The biotech and pharma sector is entering one of its most pivotal periods [...]
AskBio Announces 6 Presentations at American Society of Gene and Cell Therapy (ASGCT) 29th Annual Meeting
07/05/2026
Durham, N.C., May 07, 2026 (GLOBE NEWSWIRE) -- Three oral and 3 poster presentations demonstrate progress of AskBio’s gene therapy research, development, and manufacturing activities Viralgen continues its pioneering [...]
InStride Health Sustains Outstanding Clinical Results in Third Annual Outcomes Report; Announces State Expansion Across East Coast
07/05/2026
97% of InStride patients demonstrate clinical improvement as company nearly doubled patient enrollment in 2025 ahead of continued state expansion BOSTON, May 07, 2026 (GLOBE NEWSWIRE) -- InStride Health , the leader in [...]
Stryker declares an $0.88 per share quarterly dividend
07/05/2026
Portage, Michigan, May 07, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.88 per share payable July 31, 2026, to shareholders of record at the [...]
Dogwood Therapeutics to Report First Quarter 2026 Financial Results on Thursday, May 14, 2026
07/05/2026
ATLANTA, May 07, 2026 (GLOBE NEWSWIRE) -- Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (“Dogwood” or the “Company”), a company that focuses on developing new medicines to treat pain and neuropathy, today announced that it [...]
Xenon MRI Advances as a Cardiopulmonary Biomarker Platform at ATS 2026
07/05/2026
20+ presentations highlight expanding role in pediatric lung disease, treatment-response assessment, and pharma trial endpoints DURHAM, NC and LONDON, May 07, 2026 (GLOBE NEWSWIRE) -- Polarean, a commercial-stage [...]
Oculis Announces Agreement with FDA on a Special Protocol Assessment (SPA) for Optic Neuritis Registrational Trial
07/05/2026
ZUG, Switzerland, May 07, 2026 (GLOBE NEWSWIRE) -- Special Protocol Assessment (SPA) agreement with the U.S. FDA provides regulatory alignment on the registrational path for Privosegtor in optic neuritis (ON) FDA [...]
Most Vision Loss Is Preventable—20+ Eye Care, Neurology and Integrative Medicine Experts Unite for Free Global Summit This May
07/05/2026
Five-day virtual event during Healthy Vision Month in May will deliver science-based strategies for preventing vision loss and optimizing eye and brain health for patients and healthcare professionals With vision loss [...]
Scarlet Therapeutics Demonstrates In Vivo Survival of Lab-Grown Universal Red Blood Cells Equivalent to Donated Blood
07/05/2026
£3.2M Seed Round Closed to Accelerate Platform Development BRISTOL, United Kingdom, May 07, 2026 (GLOBE NEWSWIRE) -- Scarlet Therapeutics ("Scarlet") today announces a landmark preclinical result: its proprietary cell- [...]
TOMI Environmental Solutions (Nasdaq: TOMZ) Clarifies Previously Announced $120M Preferred Stock LOI to Merge with Carbonium Core, Entering U.S. Nuclear-Grade Graphite Market for Advanced Reactors Within a $13–15B Global Graphite Industry
07/05/2026
Establishes domestic platform in advanced graphite, addressing a multi-billion-dollar end market underpinned by U.S. supply-chain reshoring and next-generation nuclear deployment TOMI Environmental Solutions, Inc. and [...]
Moongrade Releases Astrology App Designed to Deliver Personalized Birth Charts and Unlimited Compatibility Insights
07/05/2026
Moongrade offers personalized birth charts and unlimited love compatibility insights for deeper self-discovery NEW YORK, May 07, 2026 (GLOBE NEWSWIRE) -- Moongrade has launched a personalized astrology app designed to [...]
ViaNautis Bio to present its targeted polyNaut® nanovesicles (tPNVs) for the generation of in vivo CAR-T therapies at ASGCT Annual Meeting
07/05/2026
Targeted polyNaut® nanovesicles (tPNVs) are ViaNautis’ proprietary, polymer-based delivery platform for oligonucleotides enabling cell ‑ specific targeting through nanobody conjugation CD8 nanobody conjugated tPNVs are [...]
Virbac : Declaration of the number of shares and voting rights 04/2026
07/05/2026
DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital (Article 223-16 of the General regulations of the French Financial [...]
Virbac : Déclaration d'actions et de droits de vote 04/2026
07/05/2026
DECLARATION D’ACTIONS ET DE DROITS DE VOTE Informations relatives au nombre total de droits de vote et au nombre d’actions composant le capital (Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) [...]
Angelini Pharma to Acquire Catalyst Pharmaceuticals for 4.1 Billion USD (3.5 Billion Euros), Entering the U.S. Market and Consolidating its Leadership in Brain Health and Rare Disease
07/05/2026
The Boards of Directors of Angelini Pharma and Catalyst Pharmaceuticals have unanimously approved the acquisition of Catalyst Pharmaceuticals at 31.50 USD per share in cash, for a total consideration of approximately 4. [...]
Oculis Announces Agreement with FDA on a Special Protocol Assessment (SPA) for Optic Neuritis Registrational Trial
07/05/2026
Special Protocol Assessment (SPA) agreement with the U.S. FDA provides regulatory alignment on the registrational path for Privosegtor in optic neuritis (ON) FDA Breakthrough Therapy and EMA PRIME designations in ON [...]
Kuros Biosciences appoints I.V. Hall as Chief Operating Officer, deepening operational, R&D and extremities leadership for next phase of growth
07/05/2026
Kuros Biosciences appoints I.V. Hall as Chief Operating Officer, deepening operational, R&D and extremities leadership for next phase of growth Schlieren (Zurich), Switzerland, May 7, 2026 – Kuros Biosciences (“ [...]
argenx Reports First Quarter 2026 Financial Results and Provides Business Update
07/05/2026
$1.3 billion in first quarter global product net sales, representing 63% year-over-year growth Anti - AChR antibody negative (“seronegative”) gMG PDUFA is May 10, 2026 Management to host conference call today at 2:30 PM [...]

Pages